Bottom line
SWHFX vs HGHAX: the short answer
SWHFX (Schwab Health Care Fund) and HGHAX (The Hartford Healthcare Fund) share a meaningful slice of their top holdings — about 65% by weight.
SWHFX is cheaper at 0.8% vs 1.33% — a difference of $53 a year per $10,000 invested.
HGHAX has a front-end sales load of up to 5.5%; the other does not.
Updated Nov 19, 2026
SWHFX vs HGHAX side by side
| SWHFX | HGHAX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Schwab | Hartford |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.8% | 1.33% |
| Annual cost per $10k | $80 | $133 |
| 10-yr cost on $10k (prospectus) | $990 | $2,063 |
| Max front load | — | 5.5% |
| 12b-1 fee | 0% | 0.25% |
| 1-yr return | +15.9% | — |
| 5-yr return (annualized) | +6.5% | — |
| 10-yr return (annualized) | +8.1% | — |
| Best quarter | +15.3% | +20.9% |
| Worst quarter | −12.1% | −15.7% |
| Net assets (fund) | $642.3M | $772.2M |
| Number of holdings | 80 | 80 |
| Portfolio turnover | 41% | 49% |
| Returns as of | Dec 31, 2025 | — |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | SWHFX | HGHAX | Difference |
|---|---|---|---|
| 2025 | +15.9% | +15.6% | +0.3% |
| 2024 | +0.1% | 0.0% | +0.1% |
| 2023 | +0.7% | +3.8% | −3.1% |
| 2022 | −4.7% | −11.7% | +7.1% |
| 2021 | +23.3% | +10.0% | +13.3% |
| 2020 | +12.9% | +22.6% | −9.7% |
| 2019 | +17.6% | +33.3% | −15.6% |
| 2018 | +4.0% | −3.0% | +7.0% |
| 2017 | +20.2% | +21.6% | −1.4% |
| 2016 | −4.4% | −8.6% | +4.2% |
Source: Fund prospectus bar charts
Holdings overlap
15 of SWHFX's top 25 holdings also appear in HGHAX's top 25.
| Holding | SWHFX | HGHAX |
|---|---|---|
| Eli Lilly & Co | 13.92% | 12.03% |
| Johnson & Johnson | 6.94% | 6.75% |
| AbbVie Inc | 5.81% | 4.21% |
| Merck & Co Inc | 4.98% | 6.00% |
| UnitedHealth Group Inc | 4.74% | 4.74% |
| Amgen Inc | 2.58% | 1.39% |
| Medtronic PLC | 2.29% | 1.12% |
| Thermo Fisher Scientific Inc | 2.16% | 1.58% |
| Stryker Corp | 2.11% | 1.24% |
| Vertex Pharmaceuticals Inc | 1.89% | 2.64% |
| Gsk Plc | 1.73% | 1.17% |
| Boston Scientific Corp | 1.60% | 1.88% |
| Abbott Laboratories | 1.60% | 1.82% |
| Danaher Corp | 1.47% | 2.57% |
| Elevance Health Inc | 1.45% | 3.00% |
Source: SEC Form N-PORT
SWHFX top 10
- Eli Lilly & Co — 13.92%
- Johnson & Johnson — 6.94%
- AbbVie Inc — 5.81%
- Merck & Co Inc — 4.98%
- UnitedHealth Group Inc — 4.74%
- Gilead Sciences Inc — 3.24%
- Novartis AG — 2.92%
- Amgen Inc — 2.58%
- Bristol-Myers Squibb Co — 2.44%
- Medtronic PLC — 2.29%
HGHAX top 10
- Eli Lilly & Co — 12.03%
- Johnson & Johnson — 6.75%
- Merck & Co Inc — 6.00%
- UnitedHealth Group Inc — 4.74%
- AbbVie Inc — 4.21%
- Elevance Health Inc — 3.00%
- Intuitive Surgical Inc — 2.88%
- CVS Health Corp — 2.84%
- Vertex Pharmaceuticals Inc — 2.64%
- Danaher Corp — 2.57%
FAQ
What is the difference between SWHFX and HGHAX?
Which is cheaper, SWHFX or HGHAX?
Should I own both SWHFX and HGHAX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.